Why is Nexus Surgical falling/rising?
2025-12-03 00:30:05Persistent Underperformance Against Benchmarks The recent price movement is part of a sustained period of weakness for Nexus Surgical. Over the past week, the stock has declined by 6.06%, contrasting sharply with the Sensex’s modest gain of 0.65% during the same period. This underperformance extends over longer horizons, with the stock down 17.05% in the last month while the Sensex rose 1.43%. Year-to-date figures reveal an even starker contrast: Nexus Surgical has plummeted 45.70%, whereas the Sensex has advanced by 8.96%. Over the past year, the stock’s decline of 32.84% stands in opposition to the Sensex’s 6.09% gain. Although the company’s five-year returns remain impressive at 273.88%, they still lag behind the Sensex’s 90.82% gain, indicating that recent performance has...
Read More
Nexus Surgical and Medicare Q2 FY26: Profitability Surge Masks Mounting Balance Sheet Concerns
2025-11-19 11:01:37Nexus Surgical and Medicare Ltd., a micro-cap medical essentials trading company, reported net profit of ₹0.17 crores for Q2 FY26, marking a sequential increase of 13.33% from Q1 FY26's ₹0.15 crores, though this represented a decline of 19.05% compared to ₹0.21 crores in Q2 FY25. The company, with a modest market capitalisation of ₹9.00 crores, has demonstrated improved profitability margins despite revenue volatility, yet its stock continues to languish, trading at ₹16.51 as of November 19, 2025—down 40.35% year-to-date and hovering near its 52-week low of ₹13.80.
Read MoreWhy is Nexus Surgical falling/rising?
2025-11-18 21:43:19As of 18-Nov, Nexus Surgical and Medicare Ltd is experiencing a decline in its stock price, currently at 16.80, which reflects a decrease of 0.35 or 2.04%. The stock has underperformed its sector by 1.26% today and has been on a consecutive downward trend for the last two days, resulting in a total drop of 6.56% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 42.52% compared to the 5-day average, suggesting reduced interest from investors. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Nexus Surgical has shown a 3.64% increase over the past week, which is significantly higher th...
Read MoreHow has been the historical performance of Nexus Surgical?
2025-11-17 22:53:13Answer: The historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years, culminating in the fiscal year ending March 2025. Breakdown: Nexus Surgical's net sales have increased from 1.55 Cr in March 2023 to 5.72 Cr in March 2025, indicating strong growth. Total operating income followed a similar trend, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The company's total expenditure also grew, reaching 5.06 Cr in March 2025, up from 1.34 Cr in March 2023. Despite this increase, the operating profit (PBDIT) improved from 0.21 Cr in March 2023 to 0.67 Cr in March 2025, reflecting a healthier operating profit margin of 11.54% in March 2025 compared to 13.55% in March 2023. Profit before tax also rose from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, with profit after tax increasing from 0.17 Cr to 0.50 Cr over the same period. T...
Read MoreHow has been the historical performance of Nexus Surgical?
2025-11-14 23:36:09Answer: The historical performance of Nexus Surgical shows a significant upward trend in net sales and profitability over the past few years. Breakdown: Nexus Surgical's net sales have increased from 1.55 Cr in March 2023 to 5.72 Cr in March 2025, indicating strong growth. The total operating income has followed a similar trajectory, rising from 1.55 Cr in March 2023 to 5.72 Cr in March 2025. The company's total expenditure, excluding depreciation, has also increased but at a slower rate, from 1.34 Cr in March 2023 to 5.06 Cr in March 2025, leading to an operating profit (PBDIT) of 0.67 Cr in March 2025, up from 0.22 Cr in March 2023. Profit before tax has improved from 0.23 Cr in March 2023 to 0.67 Cr in March 2025, and profit after tax has risen from 0.17 Cr to 0.50 Cr in the same period. The earnings per share (EPS) have shown a remarkable recovery, moving from -9.69 in March 2020 to 0.91 in March 2025....
Read MoreWhy is Nexus Surgical falling/rising?
2025-11-14 21:45:11As of 14-Nov, Nexus Surgical and Medicare Ltd is experiencing a price increase, with its current price at Rs 17.98, reflecting a rise of Rs 1.48 or 8.97%. The stock has outperformed its sector today by 8.21%, reaching an intraday high of Rs 17.98. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume on 13 November saw a significant increase of 117.2% compared to the 5-day average, suggesting rising investor participation. However, there is no information available regarding positive or negative factors that may have influenced this movement. In the broader market context, over the past week, Nexus Surgical has slightly underperformed the Sensex, with a return of -0.11% compared to the Sensex's +1.62%. However, in the past month, the stock has shown a strong performance with a return of +15.48%, outpacing the Sens...
Read MoreHow has been the historical performance of Nexus Surgical?
2025-11-12 23:37:48Answer: The historical performance of Nexus Surgical shows a significant increase in net sales over the years, with Mar'25 reporting net sales of 5.72 Cr, up from 3.47 Cr in Mar'24 and 1.55 Cr in Mar'23. The total operating income has also risen consistently, reaching 5.72 Cr in Mar'25 compared to 3.47 Cr in Mar'24. The company's total expenditure, excluding depreciation, was 5.06 Cr in Mar'25, which is an increase from 3.21 Cr in Mar'24. This resulted in an operating profit of 0.67 Cr for Mar'25, up from 0.29 Cr in Mar'24. Profit before tax also increased to 0.67 Cr in Mar'25 from 0.29 Cr in Mar'24, leading to a profit after tax of 0.50 Cr in Mar'25, compared to 0.21 Cr in Mar'24. The earnings per share (EPS) improved to 0.91 in Mar'25 from 0.38 in Mar'24. On the balance sheet, total assets rose to 2.27 Cr in Mar'25 from 1.80 Cr in Mar'24, while total liabilities increased to 2.27 Cr in Mar'25 from 1.80 Cr...
Read More
Nexus Surgical Faces Evaluation Adjustment Amid Flat Financial Performance and Stock Underperformance
2025-11-12 08:05:16Nexus Surgical and Medicare, a microcap in the NBFC sector, has experienced a recent score adjustment amid flat financial performance for the quarter ending June 2025. Despite a year-over-year profit increase, the stock has underperformed against the BSE500 index, raising concerns about its long-term fundamentals.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jan-2026 | Source : BSESubmission of Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation 2018 for the quarter ended 31st December 2025
Reply On Clarification Sought By Exchange
03-Jan-2026 | Source : BSESubmission of Reply on Clarification sought by the Exchange on Price Movement of the Script of the Company
Clarification sought from Nexus Surgical And Medicare Ltd
02-Jan-2026 | Source : BSEThe Exchange has sought clarification from Nexus Surgical And Medicare Ltd on January 02 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available